User profiles for DARIO CAMELLINO

Dario Camellino

SC Reumatologia, Dipartimento Apparato Locomotore, Azienda Sanitaria Locale 3, Genova
Verified email at asl3.liguria.it
Cited by 2115

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative …

…, P Perel, A Hutchings, D Camellino… - Arthritis & …, 2015 - Wiley Online Library
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international
recommendations for PMR treatment are not currently available. In this paper, we report the …

British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

…, C Dejaco, S Appenzeller, D Camellino… - …, 2020 - academic.oup.com
Background GCA is a large vessel vasculitis affecting older people, with the highest incidence
among persons 70–79 years of age [1]. Due to forecasted demographic changes, it has …

[HTML][HTML] Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data

…, E Brouwer, RRC Buchanan, D Camellino… - Seminars in Arthritis and …, 2022 - Elsevier
Objectives To determine the prevalence and predictors of subclinical giant cell arteritis (GCA)
in patients with newly diagnosed polymyalgia rheumatica (PMR). Methods PubMed, …

[HTML][HTML] Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission …

C Puppo, M Massollo, F Paparo, D Camellino… - BioMed research …, 2014 - hindawi.com
Giant cell arteritis (GCA) is the most common vasculitis affecting medium and large vessels.
It shows a close clinical association with polymyalgia rheumatica (PMR), a musculoskeletal …

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

…, D Aletaha, M Bond, E Hysa, D Camellino… - Annals of the …, 2024 - ard.bmj.com
Objectives To develop treat-to-target (T2T) recommendations in giant cell arteritis (GCA) and
polymyalgia rheumatica (PMR). Methods A systematic literature review was conducted to …

Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis

D Camellino, MA Cimmino - Rheumatology, 2012 - academic.oup.com
Objectives. Imaging is one of the most appealing techniques to explore PMR, a disease
whose causes, development mechanisms and anatomical targets of inflammatory damage are …

Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica

D Camellino, EL Matteson, F Buttgereit… - Nature Reviews …, 2020 - nature.com
Giant cell arteritis (GCA) is the most common type of primary vasculitis in Western countries.
Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease …

Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League …

…, P Perel, A Hutchings, D Camellino… - Annals of the …, 2015 - ard.bmj.com
To summarise evidence on therapeutic interventions and prognostic factors in polymyalgia
rheumatica (PMR). A systematic literature review was conducted using Ovid Medline, Embase…

Pathogenesis, diagnosis and management of polymyalgia rheumatica

D Camellino, A Giusti, G Girasole, G Bianchi, C Dejaco - Drugs & Aging, 2019 - Springer
Polymyalgia rheumatica is an inflammatory rheumatic disease of the elderly characterised
by pain and stiffness in the neck and pelvic girdle, and is the second most common …

The provisional OMERACT ultrasonography score for giant cell arteritis

…, M Aschwanden, P Bosch, D Camellino… - Annals of the …, 2023 - ard.bmj.com
Objectives To develop an Outcome Measures in Rheumatology (OMERACT) ultrasonography
score for monitoring disease activity in giant cell arteritis (GCA) and evaluate its metric …